Amunix is an immuno-oncology company leveraging Pro-XTEN technology platform to discover and develop transformative therapies for patients with cancer.
Total raised: $190M
Investors 4
| Date | Name | Website |
| - | Omega Fund... | omegafunds... |
| - | Frazier Li... | frazierls.... |
| - | Longitude ... | longitudec... |
| - | Bain Capit... | baincapita... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 08.03.2021 | Series B | $117M | BlackRock | pitchbook.... |
| 05.03.2020 | Series A | $73M | - | fiercebiot... |
Mentions in press and media 18
| Date | Title | Description | Source |
| 20.12.2021 | Sanofi to acquire Amunix immuno-oncology pipeline with next ... | Sanofi to acquire Amunix immuno-oncology pipeline with next generation Conditionally Activated Biolo... | globenewsw... |
| 08.03.2021 | Amunix Raises $117M in Series B Financing | Amunix Pharmaceuticals, Inc., a South San Francisco, CA-based biopharmaceutical company focused on d... | finsmes.co... |
| 05.03.2021 | Amunix secures $117M Series B | Biopharma startup Amunix has raised $117 million in a Series B led by Viking Global, with support fr... | pitchbook.... |
| 04.03.2021 | Amunix scores $117M to fuel T-cell engagers, cytokines for s... | Exactly one year after Amunix Pharmaceuticals raised $73 million, the tech-licensing company turned ... | fiercebiot... |
| 04.03.2021 | Amunix Raises $117 Million Series B Financing to Fund its On... | Proceeds will fund advancement of the company’s pipeline of protease-activated T cell engagers and c... | marketscre... |
| 04.03.2021 | With $117M in fresh cash, Amunix paves path to the clinic ... | Despite all the excitement over the possibility of T cell therapies to crack the code again... | endpts.com... |
| 04.03.2021 | Amunix Pharmaceuticals Receives $117M | SOUTH SAN FRANCISCO, CA, Amunix Pharmaceuticals has raised $117 million Series B financing. >&... | vcnewsdail... |
| 04.03.2021 | Amunix scores $117M to fuel T-cell engagers, cytokines for s... | Exactly one year after Amunix Pharmaceuticals raised $73 million, the tech-licensing company turned ... | fiercebiot... |
| 04.03.2021 | Amunix Raises $117 Million Series B Financing to Fund its On... | Proceeds will fund advancement of the company’s pipeline of protease-activated T cell engagers and c... | globenewsw... |
| 11.03.2020 | Biopharmaceutical Company Amunix Closes $73 Million In Fundi... | Amunix Pharmaceuticals, a biopharmaceutical company focused on developing prodrugs, announced it rai... | pulse2.com... |
Show more